Category Archives: Agency Insight

Biosimilars Spend to Reach $2.5 Bln by 2015: IMS

By Ben Comer | Published: May 18, 2011
Global spending on biosimilars is expected to reach between $2 and $2.5 billion by 2015, up from $311 million in 2010, according to an IMS forecast. Total spend on biologics is expected to climb as high as $200 billion. On a call with reporters yesterday, Murray Aitken, executive director of the IMS Institute for Healthcare Informatics, [...]
Also posted in Biotech, Emerging Markets, Europe, Strategy | Tagged , , | 2 Comments

Workforce Shortage in Oncology Imminent

By Jennifer Ringler | Published: December 13, 2010
Supply and demand for oncology specialists is expected to become even more unbalanced in the US market over the next 10 years, particularly as the new health reform legislation creates more uncertainty for the reimbursement of the high cost biologic treatments now coming on stream. Several survey are documenting the shortage and suggesting that the [...]
Also posted in News | Tagged | 2 Comments

Favorite Pharma Ad of 2010

By Julian Upton | Published: December 1, 2010
Pharm Exec has begun its search for the Ad Stars, our annual feature honoring the best in Rx advertising, and we want your input. If a great advertisement for a prescription drug — TV, print, online, radio, or any other format — has sparked your attention for its purpose, creativity, and cleverness, we’d like to [...]
Also posted in Advertising | Tagged , , , | Leave a comment

Understanding Serious Adverse Events Takes Serious Cooperation

By Jennifer Ringler | Published: October 26, 2010
What if the technology is at hand to prevent adverse reactions to medicines before they start? The International Serious Adverse Events Consortium (iSAEC) came together in 2007 to research the cause of certain drug-induced serious adverse reactions, posing the question, “What if the identification of risk for adverse events were not a random development, but instead [...]
Also posted in FDA, News, R&D | Tagged , | Leave a comment

Global Market for Medicines: Regional Balance in Growth Continues to Shift, While Pipelines Begin to Show Some Promise

By Jennifer Ringler | Published: October 8, 2010
The predicted five percent to seven percent growth of the global pharma industry surpasses the four to five percent pace of increase from 2010. According to a forecast released last week by IMS Health, the value of the global pharmaceutical market is expected to grow five percent to seven percent next year, reaching $880 billion. The IMS [...]
Also posted in Global, Strategy | Tagged | Leave a comment